Depression Drugs Market To Reach Valuation Of US$ 24.3 Bn By 2030 Digital Journal
STEALTH BIOTHERAPEUTICS ANNOUNCES DATA FROM RECLAIM-2 PHASE 2 TRIAL OF ELAMIPRETIDE IN GEOGRAPHIC ATROPHY Yahoo Finance
Atsena Therapeutics Announces Presentations at ARVO 2022 Annual Meeting and ASGCT 25th Annual Meeting Yahoo Finance
Orchard Therapeutics Announces Agreement Enabling Access and Reimbursement for Libmeldy for All Eligible MLD Patients in Germany Yahoo Finance
REMINDER – MEDIA ADVISORY: Press Conference: Masks Needed to Protect Against COVID Variants: Health Experts Call on Public Health Officials to Take Action Yahoo Finance
BELLUS Health to Present Late-Breaking Clinical Data from the Phase 2b SOOTHE Trial of BLU-5937 at the ATS 2022 International Conference Yahoo Finance
HilleVax Announces Initiation of Phase 2b Clinical Trial of HIL-214 Vaccine Candidate for the Prevention of Norovirus-Related Acute Gastroenteritis in Infants Yahoo Finance
Talaris Therapeutics Announces Upcoming Presentations at American Transplant Congress Yahoo Finance
Orphalan announces FDA approval of Cuvrior™ for the treatment of adult patients with stable Wilson’s disease who are de-coppered and tolerant to penicillamine Yahoo Finance
Oncolytics Biotech® and SOLTI Announce Upcoming Poster Presentation at the European Society for Medical Oncology Breast Cancer Meeting Yahoo Finance
